I agree that this site is using cookies. You can find further informations here.
X
Pétavy, Frank
37  results:
Search for persons X
?
1

Possible data-generating models of longitudinal continuous ..:

Mitroiu, Marian ; Teerenstra, Steven ; Oude Rengerink, Katrien..
Statistics in Biopharmaceutical Research.  , 2024
Link: https://doi.org/10.1080/..
 
?
2

Use of Clinical Data Interchange Standards Consortium (CDIS..:

Facile, Rhonda ; Muhlbradt, Erin Elizabeth ; Gong, Mengchun...
JMIR Medical Informatics.  10 (2022)  1 - p. e30363 , 2022
Link: https://doi.org/10.2196/..
 
?
3

A Simulation Study on the Estimation of the Effect in the H..:

Lasch, Florian ; Guizzaro, Lorenzo ; Pétavy, Frank.
Statistics in Biopharmaceutical Research.  15 (2022)  2 - p. 386-399 , 2022
Link: https://doi.org/10.1080/..
 
?
4

The Impact of COVID‐19 on the Initiation of Clinical Trials..:

Lasch, Florian ; Psarelli, Eftychia‐Eirini ; Herold, Ralf...
Clinical Pharmacology & Therapeutics.  111 (2022)  5 - p. 1093-1102 , 2022
Link: https://doi.org/10.1002/..
 
?
5

Estimation of treatment effects in short‐term depression st..:

Mitroiu, Marian ; Teerenstra, Steven ; Oude Rengerink, Katrien..
Pharmaceutical Statistics.  21 (2022)  5 - p. 1037-1057 , 2022
Link: https://doi.org/10.1002/..
 
?
6

Beyond "Intent‐to‐treat" and "Per protocol": Improving asse..:

Pétavy, Frank ; Guizzaro, Lorenzo ; Antunes dos Reis, Inês..
British Journal of Clinical Pharmacology.  86 (2020)  7 - p. 1235-1239 , 2020
Link: https://doi.org/10.1111/..
 
?
7

Rethinking the intention-to-treat principle: one size does ..:

Oude Rengerink, Katrien ; Mitroiu, Marian ; Teerenstra, Steven..
Journal of Clinical Epidemiology.  125 (2020)  - p. 198-200 , 2020
Link: https://doi.org/10.1016/..
 
?
8

EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Tr..:

Papadouli, Irene ; Mueller-Berghaus, Jan ; Beuneu, Claire...
The Oncologist.  25 (2020)  10 - p. 894-902 , 2020
Link: https://doi.org/10.1634/..
 
?
9

Current Statistical Considerations and Regulatory Perspecti..:

Collignon, Olivier ; Gartner, Christian ; Haidich, Anna‐Bettina...
Clinical Pharmacology & Therapeutics.  107 (2020)  5 - p. 1059-1067 , 2020
Link: https://doi.org/10.1002/..
 
?
10

The Use of a Variable Representing Compliance Improves Accu..:

Guizzaro, Lorenzo ; Pétavy, Frank ; Ristl, Robin.
Statistics in Biopharmaceutical Research.  13 (2020)  1 - p. 119-127 , 2020
Link: https://doi.org/10.1080/..
 
?
11

Are Novel, Nonrandomized Analytic Methods Fit for Decision ..:

Eichler, Hans‐Georg ; Koenig, Franz ; Arlett, Peter...
Clinical Pharmacology & Therapeutics.  107 (2019)  4 - p. 773-779 , 2019
Link: https://doi.org/10.1002/..
 
?
12

The changing landscape of data monitoring committees—Perspe..:

Bhattacharyya, Amit ; Gallo, Paul ; Crisp, Adam...
Biometrical Journal.  61 (2018)  5 - p. 1232-1241 , 2018
Link: https://doi.org/10.1002/..
 
?
13

Adaptive designs in clinical trials: from scientific advice..:

Collignon, Olivier ; Koenig, Franz ; Koch, Armin...
Trials.  19 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
14

The impact of parallel regulatory–health technology assessm..:

Tafuri, Giovanni ; Lucas, Inês ; Estevão, Steve...
British Journal of Clinical Pharmacology.  84 (2018)  5 - p. 1013-1019 , 2018
Link: https://doi.org/10.1111/..
 
?
15

Does access to clinical study reports from the European Med..:

Rohner, Eliane ; Grabik, Michael ; Tonia, Thomy...
PLOS ONE.  12 (2017)  12 - p. e0189309 , 2017
Link: https://doi.org/10.1371/..
 
1-15